no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men
|
Van Damme, Pierre |
|
2016 |
34 |
35 |
p. 4205-4212 8 p. |
article |
2 |
A review of testing used in seroprevalence studies on measles and rubella
|
Dimech, Wayne |
|
2016 |
34 |
35 |
p. 4119-4122 4 p. |
article |
3 |
A 16-year review of seroprevalence studies on measles and rubella
|
Dimech, Wayne |
|
2016 |
34 |
35 |
p. 4110-4118 9 p. |
article |
4 |
Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia
|
Ritz, Nicole |
|
2016 |
34 |
35 |
p. 4132-4139 8 p. |
article |
5 |
Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children
|
Hankin-Wei, Abigail |
|
2016 |
34 |
35 |
p. 4243-4249 7 p. |
article |
6 |
Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
|
Griffiths, Ulla Kou |
|
2016 |
34 |
35 |
p. 4213-4220 8 p. |
article |
7 |
Editorial Board/Aims and Scope
|
|
|
2016 |
34 |
35 |
p. IFC- 1 p. |
article |
8 |
Effects of serostatus and gender on the HRV-16-induced local immune response
|
Koch, Rebecca M. |
|
2016 |
34 |
35 |
p. 4087-4091 5 p. |
article |
9 |
Efficacy of various Marek’s disease vaccines protocols for prevention of Marek’s disease virus-induced immunosuppression
|
Faiz, Nik M. |
|
2016 |
34 |
35 |
p. 4180-4187 8 p. |
article |
10 |
Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
|
van den Dobbelsteen, Germie P.J.M. |
|
2016 |
34 |
35 |
p. 4152-4160 9 p. |
article |
11 |
Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials
|
Moa, Aye M. |
|
2016 |
34 |
35 |
p. 4092-4102 11 p. |
article |
12 |
Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification
|
Zhang, Lan |
|
2016 |
34 |
35 |
p. 4250-4256 7 p. |
article |
13 |
Monitoring vaccination coverage: Defining the role of surveys
|
Cutts, Felicity T. |
|
2016 |
34 |
35 |
p. 4103-4109 7 p. |
article |
14 |
Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection
|
Gouma, Sigrid |
|
2016 |
34 |
35 |
p. 4166-4171 6 p. |
article |
15 |
PLGA-microencapsulation protects Salmonella typhi outer membrane proteins from acidic degradation and increases their mucosal immunogenicity
|
Carreño, Juan Manuel |
|
2016 |
34 |
35 |
p. 4263-4269 7 p. |
article |
16 |
Preclinical studies on new proteins as carrier for glycoconjugate vaccines
|
Tontini, M. |
|
2016 |
34 |
35 |
p. 4235-4242 8 p. |
article |
17 |
Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador
|
Duque, Hernando |
|
2016 |
34 |
35 |
p. 4140-4144 5 p. |
article |
18 |
Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males
|
Scherr, C.L. |
|
2016 |
34 |
35 |
p. 4229-4234 6 p. |
article |
19 |
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice
|
Paes, Wayne |
|
2016 |
34 |
35 |
p. 4123-4131 9 p. |
article |
20 |
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers
|
Hansen, John |
|
2016 |
34 |
35 |
p. 4172-4179 8 p. |
article |
21 |
Temperature-mediated recombinant anthrax protective antigen aggregate development: Implications for toxin formation and immunogenicity
|
Amador-Molina, Juan C. |
|
2016 |
34 |
35 |
p. 4188-4195 8 p. |
article |
22 |
The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique
|
Haidari, Leila A. |
|
2016 |
34 |
35 |
p. 4161-4165 5 p. |
article |
23 |
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children
|
Voysey, Merryn |
|
2016 |
34 |
35 |
p. 4221-4228 8 p. |
article |
24 |
Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria–Pertussis–Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) – Immunological curiosity or canary in the mine?
|
Holt, Patrick G. |
|
2016 |
34 |
35 |
p. 4257-4262 6 p. |
article |
25 |
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay
|
Miura, Kazutoyo |
|
2016 |
34 |
35 |
p. 4145-4151 7 p. |
article |
26 |
Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges
|
Yan, Qin |
|
2016 |
34 |
35 |
p. 4196-4204 9 p. |
article |